OPKO Health is a diversified healthcare company that has production and distribution assets worldwide, multiple strategic investments and an active business development strategy.
OPKO develops, manufactures, markets, and sells a line of pharmaceutical, nutraceutical, and veterinary products and is establishing industry-leading positions in large, rapidly growing markets.
OPKO continues to explore acquisition opportunities for complementary pharmaceuticals, compounds, technologies, and businesses. OPKO Health expects future growth to arise from leveraging proprietary technology, development strengths, and the pursuit of complementary and strategic acquisitions and investments.
A subsidiary of OPKO Health, EirGen Pharma is situated in Ireland, Europe.